Opening the book…
Oncology Terminology
Oncology terminology helps health care workers describe abnormal cell growth, cancer diagnosis, treatment, and follow-up accurately. This chapter connects word parts with the behavior of cells and tissues, introduces common cancer names, and explains terms used in imaging, pathology, and treatment reports. You will practice translating professional language into clear, respectful explanations for a person receiving care.
- Apply medical language rules to build, analyze, spell, pronounce, and define selected oncology terms.
- Identify meanings of common oncology prefixes, combining forms, and suffixes.
- Describe normal cell growth and selected changes associated with neoplasia.
- Distinguish benign growths, in situ lesions, invasive cancer, and metastatic cancer.
- Differentiate tumor grade from cancer stage and interpret the components of TNM terminology.
- Categorize anatomic, diagnostic, disease and disorder, and therapeutic terms related to oncology.
- Interpret common oncology abbreviations in context.
- Identify professionals involved in cancer care and use accurate terminology in short health care scenarios.
Introduction to Oncology
Oncology is the branch of medicine concerned with cancer. An oncologist is a physician who diagnoses or treats cancer. Cancer includes many diseases in which abnormal cells grow without normal regulation and may invade nearby tissues or spread to distant sites. Many cancers form solid tumors, but cancers such as leukemia generally do not.
A neoplasm is an abnormal growth of tissue. Neoplasms may be benign, meaning noncancerous, or malignant, meaning cancerous. Benign does not mean harmless: a benign growth can press on an organ, obstruct a passageway, or produce excess hormones. A mass or nodule is a finding that needs interpretation; neither word automatically means cancer.
Cancer names often describe the tissue or organ where the cancer began. A carcinoma arises from epithelial tissue, while a sarcoma arises from connective or supportive tissues. Not all malignant tumors are carcinomas, and not all words ending in -oma name benign tumors. Melanoma, lymphoma, and myeloma are important malignant examples.
Language Matters
Use “person with cancer” or the person’s preferred wording. Avoid describing a person as a diagnosis. Explain unfamiliar words before using abbreviations, and avoid assuming that a cancer name alone predicts the outcome. Prognosis depends on multiple factors, and an individual’s experience cannot be determined from a population statistic alone.
For example, “The biopsy showed cancer cells in the tissue sample” is clearer than “Your Bx is positive for CA.” When explaining benign, say “The growth is not cancerous,” rather than promising that it cannot cause any problems.
Oncology Word Parts
A prefix appears before a root. A combining form includes a root and a combining vowel, often o. A suffix appears at the end. Word parts provide useful clues, but students must also learn the clinical meaning of the whole term.
Common Prefixes
| Prefix | Meaning | Example |
|---|---|---|
| ana- | Up, back, again; meaning depends on the term | Anaplasia |
| anti- | Against | Antineoplastic |
| apo- | Away from | Apoptosis |
| dys- | Abnormal, difficult | Dysplasia |
| ecto- | Outside, outer | Ectoderm |
| endo- | Within | Endoscopy |
| hyper- | Excessive, increased | Hyperplasia |
| hypo- | Below normal, decreased | Hypoplasia |
| meta- | Beyond, change | Metastasis |
| neo- | New | Neoplasm |
| peri- | Around | Peritumoral |
Common Combining Forms
| Combining form | Meaning | Example |
|---|---|---|
| aden/o | Gland | Adenocarcinoma |
| angi/o | Vessel | Angiogenesis |
| capsul/o | Capsule, enclosing structure | Encapsulated |
| carcin/o | Cancer | Carcinogen |
| cyt/o | Cell | Cytology |
| hemat/o | Blood | Hematology |
| hist/o | Tissue | Histology |
| immun/o | Immune protection | Immunotherapy |
| leiomy/o | Smooth muscle | Leiomyoma |
| lip/o | Fat | Lipoma |
| lymph/o | Lymph, lymphatic tissue | Lymphoma |
| melan/o | Dark pigment, black | Melanoma |
| mutat/o | Change | Mutation |
| myel/o | Bone marrow or spinal cord, depending on context | Myeloma |
| nephr/o | Kidney | Nephroblastoma |
| nod/o | Node, knot | Nodal |
| onc/o | Tumor | Oncology |
| oste/o | Bone | Osteosarcoma |
| path/o | Disease | Pathology |
| radi/o | Radiation | Radiotherapy |
| sarc/o | Flesh, connective tissue | Sarcoma |
Common Suffixes
| Suffix or ending | Meaning | Example |
|---|---|---|
| -blastoma | Tumor associated with immature or developing cells | Nephroblastoma |
| -carcinoma | Malignant epithelial tumor | Adenocarcinoma |
| -ectomy | Surgical removal | Mastectomy |
| -gen | Producing, causing | Carcinogen |
| -genesis | Formation, origin, production | Angiogenesis |
| -logist | Specialist | Oncologist |
| -logy | Study of | Oncology |
| -oma | Tumor or mass; does not establish whether benign or malignant | Lipoma, melanoma |
| -penia | Deficiency, reduced number | Neutropenia |
| -plasia | Formation, development, growth | Hyperplasia |
| -plasm | Formation, growth | Neoplasm |
| -sarcoma | Malignant connective or supportive tissue tumor | Osteosarcoma |
| -scopy | Visual examination with an instrument | Colonoscopy |
| -stasis | Standing, stopping; whole-word meaning varies | Metastasis |
| -therapy | Treatment | Chemotherapy |
The original word-part activity credited to Connie Stevens can remain a separate activity. These tables revise categories, clarify meanings, and add forms used throughout this chapter.
Building and Analyzing Terms
| Term | Word parts | Meaning |
|---|---|---|
| Oncology | onc/o + -logy | Field concerned with tumors and cancer |
| Carcinogen | carcin/o + -gen | Agent capable of causing cancer |
| Adenocarcinoma | aden/o + -carcinoma | Cancer with glandular epithelial features |
| Osteosarcoma | oste/o + -sarcoma | Malignant tumor in which cancer cells produce bone |
| Hyperplasia | hyper- + -plasia | Increased number of cells in a tissue |
| Neoplasm | neo- + -plasm | Abnormal new growth of tissue |
| Angiogenesis | angi/o + -genesis | Formation of blood vessels |
Concept Check
- Why does the ending -oma not establish that a tumor is benign?
- Which combining form refers to tissue, and which refers to cells?
- Build a term for a malignant tumor with glandular epithelial features.
Anatomy Related to Oncology
Cancer may arise in almost any part of the body. Because oncology is not one organ system, this anatomy review focuses on structures that appear repeatedly in cancer terminology.
| Structure | Relevance to oncology |
|---|---|
| Epithelial tissue | Covers surfaces and lines organs and glands; carcinomas arise here |
| Connective and supportive tissues | Include bone, cartilage, fat, and muscle; sarcomas arise in these tissue families |
| Bone marrow | Produces blood cells; involved in leukemias and several other hematologic cancers |
| Lymphatic tissue | Includes lymphocytes in lymph nodes and other sites; lymphomas arise from lymphocytes |
| Blood and lymph vessels | Can provide routes for cancer cells to travel |
| Basement membrane | A thin supporting layer beneath epithelium; its relationship to tumor cells helps distinguish in situ from invasive disease |
A lymph node is an immune system structure that filters lymph. Enlarged lymph nodes may reflect infection, inflammation, or cancer. Lymphadenopathy means abnormal or enlarged lymph nodes; it is a finding, not a synonym for lymphoma.
Physiology of Normal and Abnormal Cell Growth
Cell Division and Cell Death
Normal tissues balance cell division, specialization, and cell death. Mitosis is cell division that produces two daughter cells. Differentiation is the development of specialized cell features and functions. Apoptosis is a regulated process of programmed cell death. Cancer can develop when genetic changes disrupt the controls governing growth, division, DNA repair, or cell death.
Cancer is a genetic disease because it involves changes in genes; that does not mean every cancer is inherited. Somatic changes arise in cells during a person’s lifetime. Germline changes are present in egg or sperm cells and may be inherited. A hereditary cancer predisposition increases risk but does not guarantee cancer will develop.
Describing Changes in Tissue
| Term | Meaning | Important distinction |
|---|---|---|
| Hyperplasia | Increase in the number of cells | May be a response to normal signals or a pathologic process; not automatically cancer |
| Hypertrophy | Increase in cell size | Differs from an increase in cell number |
| Metaplasia | Replacement of one mature cell type by another | Not itself synonymous with malignancy |
| Dysplasia | Abnormal cellular appearance and tissue organization | May be precancerous in some settings; not every dysplastic lesion becomes cancer |
| Anaplasia | Marked loss of normal cellular differentiation | Often associated with aggressive malignant features |
| Neoplasia | Abnormal new tissue growth | May be benign or malignant |
These terms do not describe an inevitable sequence that every tissue follows. A hyperplastic tissue does not necessarily progress to dysplasia or cancer. Clinical meaning depends on the organ, findings, and diagnosis.
Invasion and Metastasis
Local invasion means extension into neighboring tissues. Metastasis means spread from the primary site to another part of the body, producing secondary disease. Cancer cells may travel through lymphatic or blood vessels. Angiogenesis, the formation of new blood vessels, can help supply a growing tumor.
The primary site is where the cancer began. If breast cancer spreads to the liver, the disease in the liver is metastatic breast cancer, not a new primary liver cancer. The plural of metastasis is metastases.
Concept Check
- How does hyperplasia differ from hypertrophy?
- Why does genetic not always mean inherited?
- How should colon cancer that spreads to the lung be named?
Cancer Risk and Prevention Terminology
A risk factor increases the chance of developing a condition. A carcinogen is an agent capable of causing cancer. Tobacco smoke, ultraviolet radiation, and certain infections are examples of exposures associated with cancer. Other influences include age, inherited predisposition, alcohol use, and selected environmental or occupational exposures. Not all bacteria, viruses, chemicals, or radiation exposures have the same effects.
A risk factor does not prove why an individual developed cancer. Likewise, a person without a recognized risk factor can develop cancer. Prevention means reducing risk where possible; it does not guarantee that cancer will never occur. Use factual language that avoids blame.
Screening looks for cancer or precancerous changes before symptoms appear. Diagnostic testing investigates a symptom, abnormal finding, or positive screening result. A positive screening result is not the same as a confirmed cancer diagnosis. Screening methods and eligibility depend on the cancer, age, risk, and current guidance.
Benign and Malignant Growths
| Feature | Benign growth | Malignant growth |
|---|---|---|
| Cancer status | Noncancerous | Cancerous |
| Local behavior | May enlarge or compress surrounding structures | May invade nearby tissues |
| Distant spread | Does not metastasize | May metastasize |
| Growth rate | Variable | Variable; not all cancers grow rapidly |
| Clinical effects | May cause serious problems because of location or function | Effects vary with type, location, extent, and other features |
An adenoma is a benign epithelial tumor with glandular features. A lipoma is a benign tumor of fat. A leiomyoma is a benign smooth muscle tumor; uterine fibroids are common examples. By contrast, leiomyosarcoma is malignant. The full term matters more than the last few letters alone.
Carcinoma in situ describes abnormal epithelial cells that remain confined to their original compartment without invasion into underlying tissue. In situ means “in its original place.” Invasive carcinoma has grown beyond that boundary. A lesion can be noninvasive and still require treatment or monitoring; noninvasive and benign are not interchangeable terms.
Common Cancer Families and Body Sites
Carcinomas and Sarcomas
Carcinomas include adenocarcinoma and squamous cell carcinoma. They occur in organs such as the breast, colon, lung, prostate, and skin. Sarcomas include osteosarcoma, liposarcoma, and leiomyosarcoma. A sarcoma is not named by simply adding -oma to any tissue root; learn the complete tumor name.
Leukemia Lymphoma and Myeloma
Leukemia involves blood-forming tissues and abnormal blood cells. Lymphoma arises in lymphocytes and may involve lymph nodes or other organs; it does not mean any lump in a lymph node. Hodgkin lymphoma and non-Hodgkin lymphomas are major lymphoma groupings. Myeloma is a malignancy of plasma cells, which are antibody-producing immune cells commonly found in bone marrow.
Breast and Reproductive Organs
Invasive ductal carcinoma begins in breast duct cells and extends into surrounding tissue. Invasive lobular carcinoma begins in milk-producing lobules. Ductal carcinoma in situ (DCIS) remains within ducts without invasion into surrounding breast tissue. Paget disease of the breast affects the nipple and areola and is distinct from Paget disease of bone. Breast cancer can occur in men as well as women.
Other reproductive cancer names include cervical, endometrial, ovarian, testicular, and prostate cancer. Endometrial refers to the lining of the uterus. Orchiectomy, also called orchidectomy, means surgical removal of a testicle. An inguinal orchiectomy is commonly part of testicular cancer diagnosis and treatment; additional care depends on type and stage. Fertility preservation may be discussed before treatment.
Benign prostatic hyperplasia (BPH) is noncancerous enlargement of the prostate. Urinary symptoms or an enlarged prostate do not automatically require a biopsy. Assessment may include history, examination, laboratory testing, and other investigations based on the findings. Prostate cancers vary: some grow slowly, while others behave aggressively.
Gastrointestinal and Pancreatic Cancers
Cancer may arise in the esophagus, stomach, colon, rectum, liver, or pancreas. Colorectal means pertaining to the colon and rectum. The pancreas contains exocrine tissue that produces digestive secretions and endocrine tissue that produces hormones. Most pancreatic cancers arise from exocrine tissue; pancreatic neuroendocrine tumors are a different group.
Pancreatic cancer is often difficult to treat, but effective treatments are available. Depending on the disease and the person’s situation, options may include surgery, chemotherapy, radiation, or selected targeted or immune treatments. Prognosis varies with the cancer type, stage, and response to treatment.
Skin Cancers
Basal cell carcinoma and squamous cell carcinoma are common skin cancers. Melanoma arises from melanocytes, the pigment-producing cells. Although melanoma can spread and become life-threatening, outcomes depend on stage and other features; the name should not be defined simply as “a deadly skin cancer.” Skin cancer can occur in any skin tone.
The ABCDE features help describe suspicious pigmented lesions. They are recognition clues rather than a diagnosis.
| Letter | Feature | Description |
|---|---|---|
| A | Asymmetry | One half differs from the other |
| B | Border | Irregular, notched, blurred, or poorly defined edges |
| C | Color | Uneven or varied color |
| D | Diameter | Often greater than 6 mm, but melanoma may be smaller |
| E | Evolving | Change in size, shape, color, symptoms, or other features |
An irregular border does not establish that cancer has spread. Evolving is broader than elevation: a lesion does not need to be raised to be concerning. A new or changing lesion warrants clinical assessment.
Urinary and Endocrine Cancers
Renal cell carcinoma arises in kidney tissue. Urothelial carcinoma commonly involves the bladder lining and may occur elsewhere in the urinary tract. Wilms tumor, also called nephroblastoma, is a childhood kidney cancer. It is not accurate to assume every affected child was born with a detectable tumor. Treatment commonly combines surgery and chemotherapy, with radiation in selected cases; many children can be cured.
Thyroid cancers differ in behavior and treatment. Thyroidectomy means removal of part or all of the thyroid gland. After total thyroidectomy, thyroid hormone replacement is needed. Some thyroid cancers may also be treated with radioactive iodine or other therapies; treatment is not identical for every thyroid tumor.
Diagnostic Tools and Pathology
Biopsy and Tissue Examination
A biopsy removes cells or tissue for examination. An incisional biopsy samples part of a lesion; an excisional biopsy removes the entire lesion for evaluation. A needle biopsy obtains a sample through a needle. Cytology examines cells, while histology examines tissue structure. A pathologist interprets laboratory and tissue findings.
A pathology report may identify the tumor type, grade, invasion, margin status, and other features. A surgical margin is the edge of removed tissue. A negative margin means cancer cells were not identified at the examined edge; a positive margin means cancer cells were found there. Margin status alone does not describe the extent of disease elsewhere in the body.
Imaging and Endoscopy
Computed tomography (CT) uses x-rays to create detailed cross-sectional images. Magnetic resonance imaging (MRI) uses magnetic fields and radio waves. Ultrasound uses sound waves. Positron emission tomography (PET) uses a radioactive tracer to show selected metabolic activity. Imaging can locate abnormalities and help assess disease extent, but an imaging finding does not always establish its cause.
Endoscopy uses an instrument to view an internal structure. Colonoscopy examines the colon and may allow removal of a polyp or collection of a biopsy. Some procedures can be used for screening or diagnosis, depending on why they are performed.
Laboratory Tests and Biomarkers
A complete blood count (CBC) measures blood cells. A fecal occult blood test (FOBT) looks for hidden blood in stool; a fecal immunochemical test (FIT) detects human blood using antibodies. A positive stool screening test requires follow-up and does not itself confirm colorectal cancer.
A tumor marker or biomarker is a measurable characteristic that can provide information about disease. Examples include prostate-specific antigen (PSA), estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). The role of a marker depends on the cancer and test: it may help assess risk, guide treatment, monitor response, or detect recurrence.
Biomarker testing of a tumor may identify changes that help guide treatment. A liquid biopsy looks for tumor-related material in a body fluid, often blood. Tumor testing and testing for inherited cancer susceptibility answer different questions. A marker result alone may not confirm or exclude cancer, and finding a target does not guarantee a response to treatment.
Screening and Symptom Awareness
Knowing usual breast or testicular appearance and reporting a new change can support timely evaluation. Breast self-examination is not a substitute for recommended screening mammography. There is no standard routine testicular cancer screening test for everyone. Neither BSE nor TSE should be presented as a universal requirement that determines whether a person has cancer.
Tumor Grade and Cancer Stage
Grade
Grade describes microscopic tumor features, including how abnormal cells look and how differentiated they are. In general, higher-grade tumors tend to behave more aggressively. Grading systems vary; some use numbers, others low and high categories, and some use specialized scores. Grade is not a universal I-to-IV measurement of cancer severity.
Stage
Stage describes the extent of disease. Clinical staging uses information such as examination, imaging, and biopsies before definitive treatment. Pathologic staging adds findings from surgery and examination of removed tissue when applicable. Grade and stage answer different questions; a high-grade tumor is not automatically stage IV.
TNM Terminology
TNM is used for many solid tumors, with definitions specific to each cancer.
| Component | What it describes |
|---|---|
| T | Size or local extent of the primary tumor |
| N | Involvement of regional lymph nodes |
| M | Presence or absence of distant metastasis |
In many TNM systems, M0 indicates no evidence of distant metastasis and M1 indicates distant metastasis. Nodal involvement does not automatically mean distant metastasis. A designation such as T2 must be interpreted using the rules for that cancer; it does not always mean a tumor is 2 cm.
Many cancers use overall stages 0 through IV. Stage 0 commonly describes carcinoma in situ; stages I through III describe increasing local or regional extent, with cancer-specific differences; stage IV commonly indicates distant spread. Blood cancers and some other tumors use different systems, and some cancers do not use every stage.
Concept Check
- Which describes microscopic cellular features: grade or stage?
- What does the N in TNM describe?
- Does a negative surgical margin prove that no cancer exists elsewhere?
Cancer Treatments and Therapeutic Terminology
Treatment may aim to cure disease, control its growth, reduce the chance of recurrence, or relieve symptoms. Plans depend on cancer type, extent, biomarkers, health status, and the person’s goals. Local treatments act mainly on a defined area; systemic treatments travel through the body. A person may receive several treatment types.
Surgery and Radiation Therapy
Surgery may remove a tumor, obtain diagnostic tissue, or relieve symptoms. Resection means removal of tissue or part or all of an organ. Debulking removes part of a tumor mass when complete removal is not possible or appropriate. Lumpectomy removes a breast lesion with surrounding tissue; mastectomy removes breast tissue.
Radiation therapy uses radiation to damage cancer cells. External beam radiation comes from a machine outside the body. Brachytherapy places a radiation source in or near the treatment area. Some radiopharmaceutical treatments are systemic. Radiation used to create a diagnostic image and radiation delivered as treatment have different purposes.
Chemotherapy and Other Drug Treatments
Cytotoxic chemotherapy kills cells or interferes with cell division. It may also affect healthy rapidly dividing cells. A regimen is a planned treatment schedule, and a cycle includes treatment and an interval before the next treatment. Antineoplastic means acting against neoplastic growth.
| Drug category | General action or purpose |
|---|---|
| Alkylating agents | Damage DNA and interfere with cell replication |
| Antimetabolites | Interfere with processes needed to make DNA or RNA |
| Microtubule inhibitors | Disrupt structures needed for cell division |
| Targeted therapies | Act on selected molecular features involved in cancer growth or survival |
| Immunotherapies | Help the immune system recognize or attack cancer |
| Hormone therapies | Reduce hormone production or block hormone effects in hormone-sensitive cancers |
These categories do not mean every drug has the same risks or works for every cancer. Some treatments overlap categories; for example, certain monoclonal antibodies can be described as targeted therapy and immunotherapy. Targeted therapy can still cause serious adverse effects.
Stem Cell Transplantation
Hematopoietic stem cell transplantation restores blood-forming cells after certain intensive treatments. Autologous transplantation uses the person’s own cells; allogeneic transplantation uses donor cells. Stem cells may come from peripheral blood, bone marrow, or cord blood. Bone marrow transplant is one form of this treatment, not a routine therapy for every bone or muscle cancer.
Timing and Goals of Treatment
| Term | Meaning |
|---|---|
| Neoadjuvant therapy | Treatment given before the main treatment, often to reduce tumor size |
| Adjuvant therapy | Additional treatment after the primary treatment to reduce recurrence risk |
| Maintenance therapy | Treatment continued to help sustain disease control in selected conditions |
| Active surveillance | Planned monitoring, with treatment considered if defined changes occur |
| Palliative care | Care addressing symptoms, distress, and quality of life alongside other appropriate care |
Palliative care can begin at diagnosis and may accompany treatment intended to cure cancer. It is not synonymous with hospice. Hospice generally emphasizes comfort when care is directed toward the end of life; eligibility and services depend on the care system.
Treatment Effects and Supportive Care Vocabulary
Side effects vary by therapy and person. Understanding these terms supports accurate reporting and patient education.
| Term | Meaning |
|---|---|
| Alopecia | Hair loss |
| Anemia | Reduced red blood cells or hemoglobin, affecting oxygen-carrying capacity |
| Neutropenia | Low neutrophil count, which can increase infection risk |
| Thrombocytopenia | Low platelet count, which can increase bleeding risk |
| Mucositis | Inflammation or injury of a mucous membrane, often involving the mouth or digestive tract |
| Peripheral neuropathy | Nerve dysfunction that may cause numbness, tingling, pain, or weakness |
| Lymphedema | Swelling related to impaired lymph drainage |
| Extravasation | Leakage of an infused substance from a vessel into surrounding tissue |
| Antiemetic | Medication used to prevent or relieve nausea and vomiting |
Fever or other signs of infection during treatment, especially with neutropenia, require prompt contact with the treating team. The team provides instructions about when and how to seek urgent assessment. A terminology learner should recognize the concern without assuming the cause or selecting treatment independently.
Remission Recurrence and Survivorship
Remission means a reduction or disappearance of signs and symptoms of cancer. Complete remission means all detectable signs of cancer have disappeared; partial remission means disease has decreased but remains detectable. Complete remission is not a guarantee that cancer will never return. Recurrence means cancer has returned after a period when it was not detected. Progression means the disease is growing or spreading.
No evidence of disease (NED) describes current test findings. Prognosis is an estimate of the likely course or outcome. Survivorship includes health and quality-of-life concerns following a cancer diagnosis, including during and after treatment. Follow-up may address recurrence, late effects, daily function, emotional well-being, and other health needs.
Oncology Medical Abbreviations
Interpret abbreviations in context and follow the care setting’s approved usage. CA can mean cancer, while Ca commonly denotes calcium; confirm the intended meaning rather than relying only on capitalization.
| Abbreviation | Meaning |
|---|---|
| ANC | Absolute neutrophil count |
| BCC | Basal cell carcinoma |
| BMT | Bone marrow transplant |
| BPH | Benign prostatic hyperplasia |
| BSE | Breast self-examination; not a replacement for recommended screening |
| Bx | Biopsy |
| CBC | Complete blood count |
| CIS | Carcinoma in situ |
| CT | Computed tomography |
| DCIS | Ductal carcinoma in situ |
| ER and PR | Estrogen receptor and progesterone receptor |
| FIT | Fecal immunochemical test |
| FOBT | Fecal occult blood test |
| HER2 | Human epidermal growth factor receptor 2 |
| HSCT | Hematopoietic stem cell transplantation |
| mets | Informal shorthand for metastases; spell out in patient education |
| MRI | Magnetic resonance imaging |
| NED | No evidence of disease |
| PET | Positron emission tomography |
| PSA | Prostate-specific antigen |
| SCC | Squamous cell carcinoma in this context; may have other meanings |
| TNM | Tumor, regional nodes, distant metastasis |
| TSE | Testicular self-examination; not a universal routine screening requirement |
Pronouncing Selected Oncology Terms
Pronunciations are approximate. Capital letters identify the stressed syllable; accepted pronunciations may vary.
| Term | Pronunciation | Everyday meaning |
|---|---|---|
| Oncology | on-KOL-uh-jee | Field of cancer medicine |
| Neoplasm | NEE-oh-plaz-um | Abnormal tissue growth |
| Benign | bih-NINE | Not cancerous |
| Malignant | muh-LIG-nunt | Cancerous |
| Carcinoma | kar-sih-NOH-muh | Cancer arising from epithelial cells |
| Sarcoma | sar-KOH-muh | Cancer arising from connective or supportive tissues |
| Metastasis | meh-TAS-tuh-sis | Spread of cancer to another site |
| Metastases | meh-TAS-tuh-seez | Plural of metastasis |
| Biopsy | BY-op-see | Removal of a sample for examination |
| Neutropenia | noo-troh-PEE-nee-uh | Low neutrophil count |
| Thrombocytopenia | throm-boh-sy-toh-PEE-nee-uh | Low platelet count |
| Angiogenesis | an-jee-oh-JEN-eh-sis | Formation of blood vessels |
Health Care Professionals in Oncology
Cancer care is often provided by a team. Professional responsibilities depend on training, credentials, and the setting.
| Professional | General role |
|---|---|
| Medical oncologist | Manages cancer using medications and coordinates care |
| Surgical oncologist | Uses surgery to diagnose or treat cancer |
| Radiation oncologist | Plans and oversees radiation treatment |
| Hematologist oncologist | Treats blood disorders and blood-related cancers |
| Pathologist | Interprets tissue, cell, and laboratory findings |
| Radiologist | Interprets medical images and may perform image-guided procedures |
| Oncology nurse | Assesses symptoms, provides treatment and education, and coordinates care |
| Oncology pharmacist | Helps evaluate regimens, medication safety, interactions, and supportive medicines |
| Genetic counselor | Explains inherited risk, testing options, and implications for individuals and families |
| Dietitian and oncology social worker | Support nutrition and practical, emotional, or resource needs within their respective professions |
Medical Terminology in Context
These fictional scenarios are for vocabulary practice and do not supply enough information to make treatment decisions.
Scenario One
A pathology report identifies invasive ductal carcinoma of the breast. The report describes a high-grade tumor, while the oncology assessment notes no evidence of distant metastasis on the completed evaluation.
- Which words describe the tissue of origin and invasion?
- Does high-grade automatically mean stage IV? Explain.
- Translate “no evidence of distant metastasis” into everyday language.
Scenario Two
Biopsy of a liver lesion shows cells consistent with the person’s previously diagnosed colon adenocarcinoma. The clinician documents metastatic colorectal cancer.
- Which organ is the primary site?
- Why is the liver lesion not automatically called primary liver cancer?
- Identify the word parts in adenocarcinoma.
Scenario Three
After chemotherapy, Morgan’s CBC shows a reduced neutrophil count. Morgan reports a fever. The nurse contacts the oncology team promptly and documents concern for infection during neutropenia.
- Expand CBC.
- Define neutropenia and identify its suffix.
- Why does the fever require prompt communication?
Scenario Four
A person has surgery to remove a tumor, followed by chemotherapy to lower the risk of recurrence. The treatment plan also includes palliative care for pain and distress. The person asks, “Does palliative care mean treatment has stopped?”
- What term describes chemotherapy given after the primary treatment?
- Write a plain-language response about palliative care.
- Define recurrence.
Test Yourself
- Define oncology and oncologist.
- Explain why benign does not mean harmless.
- Distinguish carcinoma from sarcoma.
- Classify each as anatomic, diagnostic, disease and disorder, or therapeutic: lymph node; biopsy; melanoma; brachytherapy.
- Explain the difference between grade and stage.
- Expand TNM and state what each component describes.
- Is a positive FOBT a confirmed diagnosis of colorectal cancer? Explain.
- Distinguish screening from diagnostic evaluation.
- What does the E in the melanoma ABCDE features mean?
- Explain the difference between adjuvant and neoadjuvant therapy.
- Why is complete remission not necessarily the same as cure?
- Say metastasis and metastases aloud and explain the difference.
Suggested Media and Further Learning
- What Is Cancer? National Cancer Institute: https://www.cancer.gov/about-cancer/understanding/what-is-cancer. Identify one difference between benign and malignant growth.
- Cancer Staging. National Cancer Institute: https://www.cancer.gov/about-cancer/diagnosis-staging/staging. Explain grade and stage to a partner using different words for each.
-
How Do Cancer Cells Behave Differently from Healthy Ones? TED-Ed: https://youtu.be/BmFEoCFDi-w.
- Identify two terms from this chapter used or illustrated in the video.
- NCI Dictionary of Cancer Terms: https://www.cancer.gov/publications/dictionaries/cancer-terms.
- Look up one unfamiliar term, practice its pronunciation, and write an everyday-language definition.
Attributions
The original introduction and word-part material are associated with Introduction to Oncology by Connie Stevens and Marie Rutherford in Building a Medical Terminology Foundation 2e. The original word-part activity credits Connie Stevens under CC BY 4.0. The original reinforcement activity credits Open Learning at Conestoga College under CC BY 4.0. The chapter content here is revised and expanded; it does not reproduce the original interactive activities.
Source: https://ecampusontario.pressbooks.pub/medicalterminology2/chapter/oncology/. License: https://creativecommons.org/licenses/by/4.0/.
No third-party images are reproduced. Linked videos and websites retain their respective rights and terms of use.
References
Sources were consulted October 29, 2026. The chapter provides introductory terminology; cancer-specific systems and treatment recommendations require their own current clinical resources.
- National Cancer Institute. What is cancer? https://www.cancer.gov/about-cancer/understanding/what-is-cancer
- National Cancer Institute. NCI Dictionary of Cancer Terms. https://www.cancer.gov/publications/dictionaries/cancer-terms
- National Cancer Institute. Understanding cancer prognosis. https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis
- Stevens, C., and Rutherford, M. Introduction to oncology. Building a Medical Terminology Foundation 2e. https://ecampusontario.pressbooks.pub/medicalterminology2/chapter/oncology/
- National Cancer Institute. The genetics of cancer. https://www.cancer.gov/about-cancer/causes-prevention/genetics
- National Cancer Institute. Targeted therapy for cancer. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies
- National Cancer Institute. Risk factors for cancer. https://www.cancer.gov/about-cancer/causes-prevention/risk
- National Cancer Institute. What cancer screening tests check for cancer? https://www.cancer.gov/about-cancer/screening/screening-tests
- National Cancer Institute. How cancer is diagnosed. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis
- National Cancer Institute. Soft tissue sarcoma treatment. https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq
- National Cancer Institute. Types of breast cancer. https://www.cancer.gov/types/breast/breast-cancer-types
- National Cancer Institute. Testicular cancer treatment. https://www.cancer.gov/types/testicular/treatment
- National Cancer Institute. Understanding prostate changes and conditions. https://www.cancer.gov/types/prostate/understanding-prostate-changes
- National Cancer Institute. Pancreatic cancer treatment. https://www.cancer.gov/types/pancreatic/treatment
- National Cancer Institute. Skin cancer including melanoma. https://www.cancer.gov/types/skin
- National Cancer Institute. Common moles dysplastic nevi and risk of melanoma. https://www.cancer.gov/types/skin/moles-fact-sheet
- National Cancer Institute. Wilms tumor. https://www.cancer.gov/types/kidney/patient/wilms-treatment-pdq
- National Cancer Institute. Thyroid cancer treatment. https://www.cancer.gov/types/thyroid/patient/thyroid-treatment-pdq
- National Cancer Institute. Surgical pathology reports. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/pathology-reports-fact-sheet
- National Cancer Institute. Tumor markers. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet
- National Cancer Institute. Biomarker testing for cancer treatment. https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment
- National Cancer Institute. Testicular cancer screening. https://www.cancer.gov/types/testicular/screening
- National Cancer Institute. Tumor grade. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-grade
- National Cancer Institute. Cancer staging. https://www.cancer.gov/about-cancer/diagnosis-staging/staging
- National Cancer Institute. Types of cancer treatment. https://www.cancer.gov/about-cancer/treatment/types
- National Cancer Institute. Radiation therapy to treat cancer. https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy
- National Cancer Institute. Chemotherapy to treat cancer. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
- National Cancer Institute. Immunotherapy to treat cancer. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy
- National Cancer Institute. Hormone therapy to treat cancer. https://www.cancer.gov/about-cancer/treatment/types/hormone-therapy
- National Cancer Institute. Stem cell transplants in cancer treatment. https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant
- National Cancer Institute. Palliative care in cancer. https://www.cancer.gov/about-cancer/advanced-cancer/care-choices/palliative-care-fact-sheet
- National Cancer Institute. Side effects of cancer treatment. https://www.cancer.gov/about-cancer/treatment/side-effects
- National Cancer Institute. Infection and neutropenia during cancer treatment. https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- National Cancer Institute. Cancer survivorship. https://www.cancer.gov/about-cancer/coping/survivorship
- National Cancer Institute. People in health care. https://www.cancer.gov/about-cancer/managing-care/finding-cancer-care/providers
- National Library of Medicine, MedlinePlus. Your cancer care team. https://medlineplus.gov/ency/patientinstructions/000929.htm
This page titled 20: Oncology was last modified on Mon, 02 Nov 2026 02:56:41 GMT and is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by .
The book could not be loaded just now.